Cellular substances are used in cell therapy as preventative or curative medications or treatments. Transplanting hematopoietic stem cells to restore immune function following intensive leukaemia chemotherapy is a precursor to modern cell therapy. Without treatment personalization, there may be "immunogenicity," which is graft rejection brought on by an immune response from the recipient, or "graft versus host disease," which is an immune response from the graft that results in severe inflammatory syndromes.
Using autologous cells is a successful strategy to get around this problem. Indeed, personalized cell therapy represents the highest level of patient stratification because each patient receives a unique product from their own cells.
Read More:
https://cmitoc.blogspot.com/2022/12/personalized-cell-therapy-is-used-to.html
